Compare KRYS & BOKF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRYS | BOKF |
|---|---|---|
| Founded | 2015 | 1910 |
| Country | United States | United States |
| Employees | 295 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 8.0B |
| IPO Year | 2017 | 2007 |
| Metric | KRYS | BOKF |
|---|---|---|
| Price | $340.21 | $135.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 9 |
| Target Price | ★ $297.60 | $133.67 |
| AVG Volume (30 Days) | ★ 294.7K | 249.2K |
| Earning Date | 05-04-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | ★ 128.00 | 12.65 |
| EPS | 1.83 | ★ 2.58 |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $6.56 |
| Revenue Next Year | $32.53 | $5.22 |
| P/E Ratio | $187.67 | ★ $51.50 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $130.50 | $96.89 |
| 52 Week High | $356.50 | $139.73 |
| Indicator | KRYS | BOKF |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 58.41 |
| Support Level | $253.89 | $129.49 |
| Resistance Level | N/A | $136.59 |
| Average True Range (ATR) | 12.77 | 2.54 |
| MACD | 2.68 | 0.46 |
| Stochastic Oscillator | 72.67 | 84.74 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.